Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

32.97
+0.16230.49%
Post-market: 32.96-0.0050-0.02%16:10 EDT
Volume:1K
Turnover:35.22K
Market Cap:13.19M
PE:- -
High:32.98
Open:32.98
Low:32.96
Close:32.80
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.45
T/O Rate:0.27%
Dividend:0.08
Dividend Rate:0.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Edwards Lifesciences Welcomes CMS Update to Medicare TAVR Coverage Policy

Reuters
·
Yesterday

Edwards Lifesciences Corporation - Maintains Confidence in Financial Guidance for 2026

THOMSON REUTERS
·
Yesterday

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Yesterday

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Yesterday

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

Reuters
·
Sep 10

Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026

Reuters
·
Sep 10

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Sep 10

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Sep 10

Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment

GlobeNewswire
·
Sep 10

Edwards Lifesciences (EW) Gets a Buy from Citi

TIPRANKS
·
Sep 10

Hybio Pharmaceutical Advances Obesity Treatment with New Triple Agonist Clinical Trial Filing

Stock News
·
Sep 10

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

Stock News
·
Sep 10

Bank of America Reveals 5.22% Indirect Stake in Qiagen

TIPRANKS
·
Sep 10

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
Sep 10

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Sep 09

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

GlobeNewswire
·
Sep 09

Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247

GlobeNewswire
·
Sep 09

Leerink Partners Adjusts Price Target on Merck & Co. to $161 From $127, Keeps Outperform Rating

MT Newswires Live
·
Sep 09

Merck & Co Inc : Leerink Partners Raises Target Price to $161 from $127

THOMSON REUTERS
·
Sep 09